Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options

    September 2014 in “ Paediatric drugs
    Peter Riis Mikkelsen, Gregor B. E. Jemec
    Image of study
    TLDR More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.
    The review discussed the challenges of treating hidradenitis suppurativa (HS) in children and adolescents, noting the limited data and reliance on adult treatment protocols. Topical clindamycin was recommended for mild to moderate cases, while systemic treatments included antibiotics, antiandrogens, and immunosuppressants. Weight loss and endocrine evaluations were advised for obese patients. Pain management and surgery were crucial for severe cases with scarring. The review emphasized the need for more pediatric-specific research and evidence-based guidelines to improve treatment outcomes.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    1 / 1 results

      community Diagnosed with MPB at 16 (Male)

      in Treatment  55 upvotes 7 months ago
      A 16-year-old diagnosed with male pattern baldness (MPB) was prescribed hair vitamins, vitamin D, a non-ketoconazole shampoo, and redenysl + serum, with a suggestion for GFC or IHRF treatments. Some users recommended minoxidil, ketoconazole, and derma stamping, while others advised against certain treatments until the age of 18.

    Related Research

    1 / 1 results